Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Antimicrobial Agents and Chemotherapy

• Publication date

  2010-06-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/AAC.00055-10PMID 20547798PMCID PMC2935029
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extended Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae

  2012cited by this paper
• The Sanford guide to antimicrobial therapy

  2010cited by this paper
• Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

  2010cited by this paper
• PERFORMANCE STANDARDS FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING, NINTH INFORMATIONAL SUPPLEMENT

  2008cited by this paper
• Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia.

  2008cited by this paper
• Clinical significance of potential contaminants in blood cultures among patients in a medical center.

  2007cited by this paper
• Prevalence, microbiology, and clinical characteristics of extended-spectrum β-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea

  2007cited by this paper
• Enterobacter Bacteremia: Clinical Features, Risk Factors for Multiresistance and Mortality in a Chinese University Hospital

  2006cited by this paper
• Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.

  2006cited by this paper
• Dissemination of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Intensive Care Units of a Medical Center in Taiwan

  2006cited by this paper
• Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control.

  2006cited by this paper
• Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002.

  2005cited by this paper
• Extended-Spectrum β-Lactamases: a Clinical Update

  2005cited by this paper
• Variety of TEM-, SHV-, and CTX-M-Type β-Lactamases Present in Recent Clinical Isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan

  2005cited by this paper
• Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel

  2005cited by this paper
• CTX-M-2 and a New CTX-M-39 Enzyme Are the Major Extended-Spectrum Beta-Lactamases in Multiple Escherichia coli Clones Isolated in Tel Aviv, Israel

  2005cited by this paper
• Development of a Multiplex PCR and SHV Melting-Curve Mutation Detection System for Detection of Some SHV and CTX-M β-Lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan

  2005cited by this paper
• The new beta-lactamases.

  2005cited by this paper
• Mechanisms of disease: The new β-lactamases

  2005cited by this paper
• High Prevalence of Extended-Spectrum β-Lactamase-Producing Strains among Blood Isolates of Enterobacter spp. Collected in a Tertiary Hospital during an 8-Year Period and Their Antimicrobial Susceptibility Patterns

  2004cited by this paper
• Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.

  2004cited by this paper
• International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections

  2004cited by this paper
• Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001.

  2003cited by this paper
• Modification of the Double-Disk Test for Detection of Enterobacteriaceae Producing Extended-Spectrum and AmpC β-Lactamases

  2003cited by this paper
• Prevalence of Extended-Spectrum β-Lactamase-Producing Enterobacter cloacae in the Asia-Pacific Region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001

  2003cited by this paper
• Epidemiology of Extended-Spectrum β-Lactamase-Producing Enterobacter Isolates in a Spanish Hospital during a 12-Year Period

  2002cited by this paper
• The effect of statins on mortality in patients with bacteremia.

  2001cited by this paper
• Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

  2001cited by this paper
• Enterobacter spp.: pathogens poised to flourish at the turn of the century

  1997cited by this paper
• Comorbidity of chronic diseases in general practice.

  1993cited by this paper
• Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

  1991cited by this paper
• CDC definitions for nosocomial infections.

  1989cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1988cited by this paper

• Prevalence and Molecular Epidemiology of Intestinal Colonization by Multidrug-Resistant Bacteria among Hematopoietic Stem-Cell Transplantation Recipients: A Bulgarian Single-Center Study

  2024cites this paper
• Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study

  2024cites this paper
• Evaluation of an expanded antibiotic resistance gene panel on prediction of antimicrobial susceptibility results for Gram-negative bacteria in blood cultures

  2024cites this paper
• Epidemiology of extended-spectrum β-lactamases in Enterobacterales in Taiwan for over two decades

  2023cites this paper
• Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis: Running title: Carbapenem efficacy against extended-spectrum beta-lactamase-producing

  2023cites this paper
• Carbapenem-resistant Enterobacteriaceae infection in children less than one year old in an Asian medical center.

  2022cites this paper
• The Resistance Mechanisms and Clinical Impact of Resistance to the Third Generation Cephalosporins in Species of Enterobacter cloacae Complex in Taiwan

  2022cites this paper
• Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis.

  2021cites this paper
• European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM -European Society of intensive care Medicine).

  2021cites this paper
• Risk factors and clinical impact of bacteremia due to carbapenem-nonsusceptible Enterobacteriaceae: A multicenter study in southern Taiwan.

  2021cites this paper
• Prevalence of blaCTX-M Genes in Gram-Negative Bloodstream Isolates across 66 Hospitals in the United States

  2021cites this paper
• Pathogenesis of Gram-Negative Bacteremia

  2021cites this paper
• Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters

  2020cites this paper
• Clinical Impact and Risk Factors of Nonsusceptibility to Third-Generation Cephalosporins Among Hospitalized Adults with Monomicrobial Enterobacteriaceae Bacteremia in Southern Taiwan: A Multicenter Study

  2020cites this paper
• Antimicrobial escalation is not beneficial for Gram-negative bacteremia in adults who remained critically ill after appropriate empirical therapy.

  2020cites this paper
• Clinical and pathogenesis overview of Enterobacter infections

  2020cites this paper
• MOLECULAR EPIDEMIOLOGY OF MULTIDRUG RESISTANT ENTEROBACTER CLOACAE BLOOD ISOLATES FROM A UNIVERSITY HOSPITAL

  2019cites this paper
• Matrix-assisted laser desorption ionization–time of flight mass spectrometry reveals Enterococcus and Enterobacter spp. in major insect species involved in food security with resistance to common antibiotics

  2019cites this paper
• Breakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections.

  2019cites this paper
• Comparative Study Between β-Lactam/β-Lactamase Inhibitors as Alternatives for Carbapenems in the Treatment of Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae

  2019cites this paper
• Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis.

  2018cites this paper
• Intensive care unit-acquired complicated necrotizing pneumonia caused by Enterobacter cloacae: A case report.

  2018cites this paper
• Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

  2018cites this paper
• The study of risk factors and prognostic indicators in patients with bacteremia due to ESBL producing organisms

  2018cites this paper
• Defining the Relationship Between Phenotypic and Genotypic Resistance Profiles of Multidrug-Resistant Enterobacterial Clinical Isolates.

  2018cites this paper
• Clonal spread and accumulation of &bgr;‐lactam resistance determinants in Enterobacter aerogenes and Enterobacter cloacae complex isolates from infection and colonization in patients at a public hospital in Recife, Pernambuco, Brazil

  2017cites this paper
• Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis

  2017influential citation
• Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy

  2017cites this paper
• An Improved Extended-Spectrum-β-Lactamase Detection Test Utilizing Aztreonam plus Clavulanate

  2017cites this paper
• Piperacillin–tazobactam as alternative to carbapenems for ICU patients

  2017cites this paper
• Lung Talaromyces marneffei infection in an Indonesian papillary thyroid carcinoma patient

  2017cites this paper
• Predictors of Mortality in Blood Stream Infections caused by Extended Spectrum Beta Lactamase Producing Enterobacteriaceae

  2017cites this paper
• ANTIMICROBIAL SUSCEPTIBILITY OF CLINICALLY SIGNIFICANT ISOLATES OF ENTEROBACTER SPP., OBTAINED FROM PATIENTS, HOSPITALISED IN VARNA UNIVERSITY HOSPITAL DURING THE PERIOD 2014 – 2016

  2017cites this paper
• BLOODSTREAM INFECTIONS CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCING ENTEROBACTERIACEAE AT A TERTIARY CARE HOSPITAL IN SLOVAKIA

  2017cites this paper
• Extended-spectrum β-lactamase-producing Enterobacteriaceae in cell phones of health care workers from Peruvian pediatric and neonatal intensive care units.

  2016cites this paper
• Are Fluoroquinolones Appropriate for the Treatment of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli?

  2016cites this paper
• Overview of Molecular Diagnostics in Multiple-Drug-Resistant Organism Prevention: Focus on Multiple-Drug-Resistant Gram-Negative Bacterial Organisms

  2016cites this paper
• Emergence of CMY-2- and DHA-1-type AmpC β-lactamases in Enterobacter cloacae isolated from several hospitals of Qazvin and Tehran, Iran

  2016cites this paper
• Identification of bacterial contaminants in polyherbal medicines used for the treatment of tuberculosis in Amatole District of the Eastern Cape Province, South Africa, using rapid 16S rRNA technique

  2016cites this paper
• Association of antibiotic resistance with SHV-12 extended-spectrum β-lactamase in Enterobacter cloacae.

  2016cites this paper
• Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates

  2015cites this paper
• Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.

  2015cites this paper
• Infections à Enterobacter cloacae complex : résistance aux antibiotiques et traitement

  2015cites this paper
• Antibiotic consumption and molecular epidemiology of ESBL-producing escherichia coli and klebsiella pneumoniae in a Lebanese hospital

  2015influential citation
• Characterization of IS26‐composite transposons and multidrug resistance in conjugative plasmids from Enterobacter cloacae

  2015cites this paper
• Clinical Management of Infections Caused by Enterobacteriaceae that Express Extended-Spectrum β-Lactamase and AmpC Enzymes

  2015cites this paper
• Emergence of OXA-Type Extended-Spectrum β-Lactamases Among Enterobacter cloacae Isolates Collected From Hospitals of Tehran, Karaj and Qazvin, Iran

  2014influential citation
• Prevalence and impact of extended-spectrum β-lactamase production on clinical outcomes in cancer patients with Enterobacter species bacteremia

  2014cites this paper
• Cefepime therapy for monomicrobial bacteremia caused by cefepime-susceptible extended-spectrum beta-lactamase-producing Enterobacteriaceae: MIC matters.

  2013cites this paper
• Characterisation and clinical features of Enterobacter cloacae bloodstream infections occurring at a tertiary care university hospital in Switzerland: is cefepime adequate therapy?

  2013influential citation
• The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.

  2013cites this paper
• Significant publications on infectious diseases pharmacotherapy in 2012.

  2013cites this paper
• Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis.

  2012cites this paper
• β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.

  2012cites this paper
• Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.

  2012cites this paper
• Risk factors and outcome of Pseudomonas aeruginosa bacteremia among adults visiting the ED.

  2012cites this paper
• Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli

  2012cites this paper
• Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?

  2012cites this paper
• Emergence in Spain of a Multidrug-Resistant Enterobacter cloacae Clinical Isolate Producing SFO-1 Extended-Spectrum β-Lactamase

  2011cites this paper
• Characterization of Ertapenem-Resistant Enterobacter cloacae in a Taiwanese University Hospital

  2011cites this paper
• Emergence in Spain of a Multidrug-Resistant Enterobacter cloacae Clinical Isolate Producing SFO-1 Extended-Spectrum (cid:1) -Lactamase (cid:1)

  2011cites this paper
• Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Aeromonas spp. at a Medical Center in Southern Taiwan

  2011cites this paper
• ‫جٌَب‬ ّ ‫طة‬ ِ‫دٍهاٌّاه‬ ‫سيغت‬ ُ‫پضٍّشكذ‬ - ‫خ‬ ‫پششكي‬ ‫فارط‬ ‫ليج‬ ‫تَشْز‬ ‫درهاًي‬ ‫تْذاشتي‬ ‫خذهات‬ ٍ ‫پششكي‬ ‫علَم‬ ُ‫داًشگا‬

  year unknowncites this paper